Search for: "CAMPAIGN/RESPONSIBLE v. FDA"
Results 21 - 40
of 151
Sorted by Relevance
|
Sort by Date
28 Mar 2022, 12:50 am
For more resources on these campaigns, check out our commercial co-ventures resources. [read post]
18 Mar 2024, 9:30 am
This post provides a brief update.On March 26, Food and Drug Administration v. [read post]
21 Jun 2018, 8:02 am
Lilly-v-Arla-Opinion [read post]
Seventh Circuit Upholds Preliminary Injunction Issued in Favor of Elanco US, Inc. Against Arla Foods
21 Jun 2018, 8:02 am
Lilly-v-Arla-Opinion [read post]
16 Feb 2010, 8:34 am
We have no intention of wading into the treacherous (and heated) debate about Citizens United v. [read post]
7 May 2010, 12:35 pm
In Merck & Co. v. [read post]
1 Mar 2012, 6:16 am
Reynolds Tobacco Co. v. [read post]
19 Apr 2011, 5:04 pm
Highlights this week included: Aricept (Donepezil HCI) – US: Lawsuit alleges false marking based on Orange Book ‘advertising’: Pharmaceutical Technologies v Eisai (FDA Law Blog) (Patent Docs) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
6 Jul 2015, 4:39 am
Church & Dwight Co. v. [read post]
23 Jan 2023, 4:15 am
FDA (2nd Cir. [read post]
27 Mar 2012, 6:15 am
Plaintiffs can respond to claims that modified risk products are unhealthy “if and when the veracity of the health claims they make in response have been demonstrated. [read post]
24 May 2007, 10:40 am
A visceral response along the lines of, "oh, yeah - watch me," is something we've seen a lot in preemption cases. [read post]
5 Mar 2008, 6:38 am
Last week, the Court handed Riegel v Medtronic, 128 S. [read post]
7 Mar 2024, 5:00 am
In response, policymakers will need to continue to conduct balanced cost-benefit analyses based on the spectrum of public influence campaigns: If companies with a vested interest want to lobby for a particular rule extension, they should do so. [read post]
23 Jul 2010, 7:28 am
(citing Wilson v. [read post]
30 May 2017, 8:30 am
This post is the third part of a four-part series on the Fourth Circuit’s recent en banc decision in IRAP v. [read post]
16 May 2014, 5:41 pm
Today’s Iowa Supreme Court decision in Bertrand v. [read post]
3 Apr 2011, 6:59 am
The FDA campaign has two approaches. [read post]
15 Jun 2011, 4:56 am
(Patent Docs) Strattera (Atomoxetine)- US: Patent infringement complaint filed in response to Para IV certification: Eli Lilly & Co. v. [read post]
2 Apr 2014, 4:30 am
Instead, we get this gift from LEXIS/NEXIS: Whitener v. [read post]
